How many employees does Theranexus have this year?
Theranexus has 16 undefined employees this year.
Theranexus Employees 2024
Theranexus Employees
16
Theranexus Dividend yield
Ticker
ALTHX.PA
ISIN
FR0013286259
WKN
A2H6LX
In 2024, Theranexus employed 16 people, a 0% change from the 16 number of employees in the previous year.
Theranexus Aktienanalyse
What does Theranexus do?
Theranexus SA is a French biotechnology company founded in Lyon in 2013. The company specializes in the development of drugs for the treatment of neurodegenerative diseases. It is one of the few companies specialized in the synthesis of drug candidates through the combination of molecules. The idea to create Theranexus arose from the collaboration between Mathieu Charveriat and Franck Mouthon, two experienced researchers who both worked at the CNRS laboratory at the University of Lyon. Their goal was to synthesize a new class of molecules that are more effective in the treatment of neuropsychiatric disorders such as depression, anxiety, narcolepsy, and Alzheimer's. The company specializes in two main areas: the development of novel drugs and the identification of drug candidates through the modulation of molecules that influence neuronal communication. Theranexus closely collaborates with academic partners to develop a wide range of therapeutic options for neurodegenerative diseases. The company focuses on the development of drugs that work in a unique and seamless way. Theranexus SA has a unique business model in the field of drug development. The company utilizes its innovative technology platform to combine and rearticulate molecules that can influence neuronal communication. The company aims to expand its technology platform and extend its research to other disease areas. The company operates two main activities: the development of drug candidates for the treatment of neurodegenerative diseases and the identification of new drug candidates through the modulation of molecules that influence neuronal communication. The company has recently developed a cathepsin S platform that focuses on the discovery of drugs and drug candidates for the treatment of neurodegenerative diseases. Cathepsin S is an enzyme involved in the formation of amyloid deposits that can play a role in Alzheimer's disease and other neurodegenerative diseases. Theranexus has also developed a platform for the formation of nanoparticles to enable drugs to have a longer half-life and reduce dosage. The company utilizes the platform to stabilize therapeutic molecules by modifying their chemical properties in the body. Theranexus's current products include ANX-368, a drug candidate for the treatment of narcolepsy, and THN102, a combination drug for the treatment of Parkinson's and sleep disorders. The drug candidate TNX-102 is being developed as a potential medication for the treatment of neuropathic pain. Overall, Theranexus SA aims to develop effective and innovative drugs for the treatment of neurodegenerative diseases. The company is committed to expanding its technology platform and continuing its research in other disease areas. Theranexus ist eines der beliebtesten Unternehmen auf Eulerpool.com.Employees Details
Examining Theranexus's Employee Base
Theranexus's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Theranexus's operational capacity and future potential.
Year-to-Year Comparison
Assessing Theranexus's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.
Impact on Investments
Theranexus's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.
Interpreting Employee Trends
Fluctuations in Theranexus’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.
Frequently Asked Questions about Theranexus Stock
How many employees did Theranexus have compared to the previous year?
Compared to the previous year, Theranexus had 0% more employees.
What impact did the number of employees have on the company Theranexus?
The number of employees has a direct impact on the efficiency and productivity of Theranexus. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.
What impact did the number of employees have on investors of Theranexus?
The number of employees can also have an impact on investors of Theranexus, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.
How does an increase in equity capital of Theranexus affect the company?
An increase in equity of Theranexus can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.
How does a reduction in Theranexus's equity affect the company?
A reduction in equity of Theranexus can impair its financial stability and decrease its ability to fulfill future investments and obligations.
What are some factors that influence the equity of Theranexus?
Some factors that can influence the equity of Theranexus include, among others, revenue development, profit and loss statement, dividend payments, and investments.
Why is the equity of Theranexus so important for investors?
The equity of Theranexus is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.
How does the number of employees at Theranexus influence the company?
The number of employees at Theranexus can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.
How has the number of employees at Theranexus evolved in recent years?
In recent years, the number of employees at Theranexus has changed by 0.
How many employees does Theranexus currently have?
Theranexus currently has 16 undefined employees.
Why is the number of employees important for investors of Theranexus?
The number of employees is important for investors of Theranexus as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.
What strategic measures can Theranexus take to change the number of employees?
To change the number of employees, Theranexus can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.
How much dividend does Theranexus pay?
Over the past 12 months, Theranexus paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Theranexus is expected to pay a dividend of 0 EUR.
What is the dividend yield of Theranexus?
The current dividend yield of Theranexus is .
When does Theranexus pay dividends?
Theranexus pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Theranexus?
Theranexus paid dividends every year for the past 0 years.
What is the dividend of Theranexus?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Theranexus located?
Theranexus is assigned to the 'Health' sector.
Wann musste ich die Aktien von Theranexus kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Theranexus from 6/5/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 6/5/2024.
When did Theranexus pay the last dividend?
The last dividend was paid out on 6/5/2024.
What was the dividend of Theranexus in the year 2023?
In the year 2023, Theranexus distributed 0 EUR as dividends.
In which currency does Theranexus pay out the dividend?
The dividends of Theranexus are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Theranexus
Our stock analysis for Theranexus Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Theranexus Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
